[Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)]

Ugeskr Laeger. 2006 Mar 27;168(13):1341-3.
[Article in Danish]

Abstract

Post-partum haemorrhage is the most common cause of maternal death in third-world countries. The objective of this study was to evaluate whether routine administration of sublingual misoprostol, 600 g, reduces post-partum haemorrhage. Significantly fewer women in the misoprostol group experienced a loss of > or = 1,000 ml (11% vs. 17%; 0.66 (0.45-0.98)) or > or = 1,500 ml (2% vs. 8%; 0.28 (0.12-0.64)) of blood. We conclude that sublingual misoprostol reduces the frequency of severe post-partum haemorrhage.

Publication types

  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Administration, Sublingual
  • Developing Countries
  • Double-Blind Method
  • Female
  • Guinea-Bissau
  • Humans
  • Misoprostol / administration & dosage*
  • Misoprostol / adverse effects
  • Oxytocics / administration & dosage*
  • Oxytocics / adverse effects
  • Postpartum Hemorrhage / prevention & control*
  • Pregnancy
  • Tablets

Substances

  • Oxytocics
  • Tablets
  • Misoprostol